In a report released yesterday, Sean Morgan from Evercore ISI maintained a Buy rating on Cheniere Energy (LNG – Research Report), with a price target of $152.00. The company’s shares closed last Tuesday at $133.63, close to its 52-week high of $143.40.
According to TipRanks.com, Morgan is a 3-star analyst with an average return of 5.4% and a 50.0% success rate. Morgan covers the Industrial Goods sector, focusing on stocks such as New Fortress Energy, Dorian LPG, and Golar LNG.
Cheniere Energy has an analyst consensus of Strong Buy, with a price target consensus of $144.50, representing a 2.8% upside. In a report issued on February 25, Wolfe Research also maintained a Buy rating on the stock with a $151.00 price target.
Based on Cheniere Energy’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $6.56 billion and GAAP net loss of $1.32 billion. In comparison, last year the company earned revenue of $2.79 billion and had a GAAP net loss of $194 million.
Based on the recent corporate insider activity of 37 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of LNG in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cheniere Energy, Inc. engages in liquefied natural gas (LNG) related businesses. It owns and operates LNG terminals, and develops, constructs, and operates liquefaction projects near Corpus Christi, Texas, and at the Sabine Pass LNG terminal. The company was founded by Charif Souki in 1983 and is headquartered in Houston, TX.
Read More on LNG:
- Analysts Offer Insights on Financial Companies: INDUS Realty Trust (INDT), Sunstone Hotel (SHO) and VICI Properties (VICI)
- Analysts’ Opinions Are Mixed on These Healthcare Stocks: Gilead Sciences (GILD), Revance Therapeutics (RVNC) and Corbus Pharmaceuticals (CRBP)
- Wall Street Analysts Are Bullish on Top Technology Picks
- Analysts Offer Insights on Consumer Goods Companies: Advance Auto Parts (AAP), Campbell Soup (CPB) and Dollar General (DG)
- Parker Hannifin Holds Investor Meeting, Provides Long-Term Targets